PRAXPraxis Precision Medicines, Inc.

$377.25

The financials

Praxis Precision Medicines, Inc. by the numbers

For the full year FY2025, revenue was $0 (−100% year on year) and net income −$303M.

Praxis Precision Medicines, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenuen/a$0n/a
Operating income−$97M−$76Mn/a
Net income−$84M−$71Mn/a
Diluted EPS−$2.87−$3.31n/a

Business Segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Q3 2025Total $0.00
Reportable grew -100% year on year
  • Reportable$0.00year on year -100%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2025-11-05, SEC EDGAR